Castle Biosciences, Inc. Share Price

Castle Biosciences, Inc. Share Price

NASDAQ: CSTL | Small Cap
$38.51
+$1.89 (5.16%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Castle Biosciences, Inc. Stock Performance

Open
$38.10
Prev. Close
$36.62
Circuit Range
N/A
Day Range
$36.08 - $38.73
Year Range
$17.84 - $44.13
Volume
76,441
Average Traded
$38.13

Castle Biosciences, Inc. Share Price Today

As of 30 October 2026, Castle Biosciences, Inc.'s share price is $38.51. The stock opened at $38.10, compared to its previous close of $36.62. During today's trading session, Castle Biosciences, Inc.'s share price traded between $36.08 and $38.73, with an average price of $37.40. Over the past 52 weeks, the stock has recorded a high of $44.13 and a low of $17.84. In terms of performance, Castle Biosciences, Inc.'s share price has risen by 57.38% over the last six months and is up 51.02% on a year-on-year basis.

Castle Biosciences, Inc. Share Price Chart

Line chart of the Castle Biosciences, Inc. price trend over the selected period. The price rose overall, ranging from 36.08 to 38.73, ending at 38.51.
$36.08$38.73
L
Show Current Price
H

Castle Biosciences, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.12B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.64
Revenue (TTM)
$344.23B
Return On Equity (TTM)
-4.13%
Profit Margin
-7.02%
Debt to Equity
0.02
Quarterly Earnings Growth YoY
-312.00%

Castle Biosciences, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$83.04$87.01$83.68$103.55
Net Profit-$0.50-$2.33-$14.52-$2.06
Net Profit Margin-0.60%-2.68%-17.35%-1.99%
Income ChangeN/A-366.00%-523.18%85.81%

Castle Biosciences, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$137.04$219.79$332.07$344.23
Net Profit-$67.14-$57.47$18.25-$24.16
Net Profit Margin-48.99%-26.15%5.50%-7.02%
Income ChangeN/A14.40%131.76%-232.38%

About Castle Biosciences, Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Castle Biosciences, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$35.98
$38.50
+8.51%
Sep 2026
$33.39
$35.48
+3.65%
Aug 2026
$27.91
$34.23
+21.99%
Jul 2026
$23.91
$28.06
+17.75%
Jun 2026
$21.02
$23.83
+13.05%
May 2026
$24.58
$21.08
-13.85%
Apr 2026
$24.89
$24.47
-0.33%
Mar 2026
$28.66
$24.55
-16.75%
Feb 2026
$39.84
$29.49
-25.11%
Jan 2026
$39.12
$39.38
+1.31%
Dec 2025
$39.70
$38.87
-2.31%
Nov 2025
$25.91
$39.79
+56.04%

CSTL Share Price FAQs